70 related articles for article (PubMed ID: 20664000)
1. Virtual screening-based discovery and mechanistic characterization of the acylthiourea MRT-10 family as smoothened antagonists.
Manetti F; Faure H; Roudaut H; Gorojankina T; Traiffort E; Schoenfelder A; Mann A; Solinas A; Taddei M; Ruat M
Mol Pharmacol; 2010 Oct; 78(4):658-65. PubMed ID: 20664000
[TBL] [Abstract][Full Text] [Related]
2. Discovery, molecular and pharmacological characterization of GSA-10, a novel small-molecule positive modulator of Smoothened.
Gorojankina T; Hoch L; Faure H; Roudaut H; Traiffort E; Schoenfelder A; Girard N; Mann A; Manetti F; Solinas A; Petricci E; Taddei M; Ruat M
Mol Pharmacol; 2013 May; 83(5):1020-9. PubMed ID: 23448715
[TBL] [Abstract][Full Text] [Related]
3. Identification and mechanism of action of the acylguanidine MRT-83, a novel potent Smoothened antagonist.
Roudaut H; Traiffort E; Gorojankina T; Vincent L; Faure H; Schoenfelder A; Mann A; Manetti F; Solinas A; Taddei M; Ruat M
Mol Pharmacol; 2011 Mar; 79(3):453-60. PubMed ID: 21177415
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays.
Lu W; Zhang D; Ma H; Tian S; Zheng J; Wang Q; Luo L; Zhang X
Eur J Med Chem; 2018 Jul; 155():34-48. PubMed ID: 29857275
[TBL] [Abstract][Full Text] [Related]
5. Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity.
Solinas A; Faure H; Roudaut H; Traiffort E; Schoenfelder A; Mann A; Manetti F; Taddei M; Ruat M
J Med Chem; 2012 Feb; 55(4):1559-71. PubMed ID: 22268551
[TBL] [Abstract][Full Text] [Related]
6. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.
Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M
FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740
[TBL] [Abstract][Full Text] [Related]
7. Evidence for allosteric interactions of antagonist binding to the smoothened receptor.
Rominger CM; Bee WL; Copeland RA; Davenport EA; Gilmartin A; Gontarek R; Hornberger KR; Kallal LA; Lai Z; Lawrie K; Lu Q; McMillan L; Truong M; Tummino PJ; Turunen B; Will M; Zuercher WJ; Rominger DH
J Pharmacol Exp Ther; 2009 Jun; 329(3):995-1005. PubMed ID: 19304771
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of Hedgehog modulator properties after functional coupling of Smoothened to G15.
Masdeu C; Faure H; Coulombe J; Schoenfelder A; Mann A; Brabet I; Pin JP; Traiffort E; Ruat M
Biochem Biophys Res Commun; 2006 Oct; 349(2):471-9. PubMed ID: 16945339
[TBL] [Abstract][Full Text] [Related]
9. Small molecule antagonists in distinct binding modes inhibit drug-resistant mutant of smoothened.
Tao H; Jin Q; Koo DI; Liao X; Englund NP; Wang Y; Ramamurthy A; Schultz PG; Dorsch M; Kelleher J; Wu X
Chem Biol; 2011 Apr; 18(4):432-7. PubMed ID: 21513879
[TBL] [Abstract][Full Text] [Related]
10. [Structure of the Smoothened receptor].
Ruat M; Hoch L; Faure H; Rognan D
Med Sci (Paris); 2013 Oct; 29(10):855-60. PubMed ID: 24148123
[TBL] [Abstract][Full Text] [Related]
11. Structural optimization on a virtual screening hit of smoothened receptor.
Song S; Jiang J; Zhao L; Wang Q; Lu W; Zheng C; Zhang J; Ma H; Tian S; Zheng J; Luo L; Li Y; Yang ZJ; Zhang X
Eur J Med Chem; 2019 Jun; 172():1-15. PubMed ID: 30939349
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of smoothened receptor antagonists by binding kinetics against drug-resistant mutant.
Shimizu Y; Ishii T; Ogawa K; Sasaki S; Matsui H; Nakayama M
Eur J Pharmacol; 2015 Oct; 764():220-227. PubMed ID: 26048307
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and structure--activity-relationship of tetrahydrothiazolopyridine derivatives as potent smoothened antagonists.
Ma H; Lu W; Sun Z; Luo L; Geng D; Yang Z; Li E; Zheng J; Wang M; Zhang H; Yang S; Zhang X
Eur J Med Chem; 2015 Jan; 89():721-32. PubMed ID: 25462278
[TBL] [Abstract][Full Text] [Related]
14. Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonists.
Lucas BS; Aaron W; An S; Austin RJ; Brown M; Chan H; Chong A; Hungate R; Huang T; Jiang B; Johnson MG; Kaizerman JA; Lee G; McMinn DL; Orf J; Powers JP; Rong M; Toteva MM; Uyeda C; Wickramasinghe D; Xu G; Ye Q; Zhong W
Bioorg Med Chem Lett; 2010 Jun; 20(12):3618-22. PubMed ID: 20493695
[TBL] [Abstract][Full Text] [Related]
15. The development of a high-content screening binding assay for the smoothened receptor.
Bee WT; Xie W; Truong M; Will M; Turunen B; Zuercher WJ; McMillan L; Li H; Hornberger KR; Davenport EA; Ames RS; Kallal LA
J Biomol Screen; 2012 Aug; 17(7):900-11. PubMed ID: 22644265
[TBL] [Abstract][Full Text] [Related]
16. N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists.
Muraglia E; Ontoria JM; Branca D; Dessole G; Bresciani A; Fonsi M; Giuliano C; Llauger Bufi L; Monteagudo E; Palumbi MC; Torrisi C; Rowley M; Steinkühler C; Jones P
Bioorg Med Chem Lett; 2011 Sep; 21(18):5283-8. PubMed ID: 21802943
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics.
Peukert S; Miller-Moslin K
ChemMedChem; 2010 Apr; 5(4):500-12. PubMed ID: 20229564
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis.
Sicklick JK; Li YX; Jayaraman A; Kannangai R; Qi Y; Vivekanandan P; Ludlow JW; Owzar K; Chen W; Torbenson MS; Diehl AM
Carcinogenesis; 2006 Apr; 27(4):748-57. PubMed ID: 16339184
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance.
Dijkgraaf GJ; Alicke B; Weinmann L; Januario T; West K; Modrusan Z; Burdick D; Goldsmith R; Robarge K; Sutherlin D; Scales SJ; Gould SE; Yauch RL; de Sauvage FJ
Cancer Res; 2011 Jan; 71(2):435-44. PubMed ID: 21123452
[TBL] [Abstract][Full Text] [Related]
20. Ligand-based 3D pharmacophore modeling, virtual screening, and molecular dynamic simulation of potential smoothened inhibitors.
Mohebbi A
J Mol Model; 2023 Apr; 29(5):143. PubMed ID: 37062794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
